Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Tagamet HB ad

This article was originally published in The Tan Sheet

Executive Summary

Tagamet HB ad: TV advertising that began April 13 touts Tagament HB as the only OTC H2 antagonist to be approved "in a full prescription strength" and for being at the "same strength doctors have prescribed to safely treat heartburn for over 15 years." The ad also claims that "nothing stops stomach acid faster." The campaign is being handled by Ogilvy & Mather. Tagamet HB is approved in 200 mg doses up to twice daily. The lowest Rx dose for Tagamet -- 400 mg -- is approved for maintenance therapy in patients with duodenal ulcers...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085017

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel